Sylvie Labrecque

1.4k total citations · 1 hit paper
10 papers, 1.2k citations indexed

About

Sylvie Labrecque is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Sylvie Labrecque has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Sylvie Labrecque's work include Cancer-related Molecular Pathways (6 papers), Cervical Cancer and HPV Research (4 papers) and Cancer Research and Treatments (3 papers). Sylvie Labrecque is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Cervical Cancer and HPV Research (4 papers) and Cancer Research and Treatments (3 papers). Sylvie Labrecque collaborates with scholars based in Canada, Slovakia and Italy. Sylvie Labrecque's co-authors include Greg Matlashewski, Lawrence Banks, Miranda Thomas, Ann Kalita, David Pim, David M. Thomson, Suiyang Li, Sandra Pellegrini, Andrew Cuddihy and Maria Cristina Gauzzi and has published in prestigious journals such as The Journal of Immunology, Molecular and Cellular Biology and Oncogene.

In The Last Decade

Sylvie Labrecque

10 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically

1999 603 citations Miranda Thomas, Ann Kalita et al. Molecular and Cellular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sylvie Labrecque Canada	9	738	532	382	228	224	10	1.2k
Chunxiao Xu United States	16	645 0.9×	541 1.0×	587 1.5×	162 0.7×	528 2.4×	29	1.8k
Katherine Ruffner United States	12	823 1.1×	678 1.3×	577 1.5×	152 0.7×	218 1.0×	31	2.0k
Michel Barrois France	29	965 1.3×	1.2k 2.2×	382 1.0×	403 1.8×	91 0.4×	53	2.3k
P K Pattengale United States	22	487 0.7×	572 1.1×	114 0.3×	109 0.5×	502 2.2×	38	1.6k
Dorothy L. Buchhagen United States	17	643 0.9×	702 1.3×	244 0.6×	237 1.0×	156 0.7×	26	1.4k
R Greaves United Kingdom	15	891 1.2×	876 1.6×	942 2.5×	200 0.9×	289 1.3×	15	2.0k
P. A. Bunn United States	14	837 1.1×	378 0.7×	362 0.9×	163 0.7×	486 2.2×	39	1.6k
Matthias Karrasch Germany	16	576 0.8×	486 0.9×	400 1.0×	128 0.6×	197 0.9×	42	1.5k
Polly R. Etkind United States	19	221 0.3×	548 1.0×	496 1.3×	120 0.5×	245 1.1×	30	1.2k
Sebastian Ochsenreither Germany	22	788 1.1×	445 0.8×	328 0.9×	96 0.4×	531 2.4×	103	1.6k

Countries citing papers authored by Sylvie Labrecque

Since Specialization

Citations

This map shows the geographic impact of Sylvie Labrecque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Labrecque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Labrecque more than expected).

Fields of papers citing papers by Sylvie Labrecque

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Labrecque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Labrecque. The network helps show where Sylvie Labrecque may publish in the future.

Co-authorship network of co-authors of Sylvie Labrecque

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Labrecque. A scholar is included among the top collaborators of Sylvie Labrecque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Labrecque. Sylvie Labrecque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Ghosh, Anirban, Sylvie Labrecque, & Greg Matlashewski. (2001). Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response. Vaccine. 19(23-24). 3169–3178. 55 indexed citations

2.

Zhang, Wen‐Wei, et al.. (2000). Development of a p53 responsive GFP reporter; identification of live cells with p53 activity. Journal of Biotechnology. 84(1). 79–86. 11 indexed citations

3.

Makni, Héla, Eduardo L. Franco, Jane Haruko Lima Kaiano, et al.. (2000). p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation. International Journal of Cancer. 87(4). 528–533. 75 indexed citations

4.

Makni, Héla, Eduardo L. Franco, Jane Haruko Lima Kaiano, et al.. (2000). p53 polymorphism in codon 72 and risk of human papillomavirus‐induced cervical cancer: effect of inter‐laboratory variation. International Journal of Cancer. 87(4). 528–533. 7 indexed citations

5.

Thomas, Miranda, Ann Kalita, Sylvie Labrecque, et al.. (1999). Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically. Molecular and Cellular Biology. 19(2). 1092–1100. 603 indexed citations breakdown →

6.

Li, Suiyang, Sylvie Labrecque, Maria Cristina Gauzzi, et al.. (1999). The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α. Oncogene. 18(42). 5727–5737. 220 indexed citations

7.

Labrecque, Sylvie, et al.. (1995). Viability of wild type p53-containing and p53-deficient tumor cells following anticancer treatment: the use of human papillomavirus E6 to target p53.. PubMed. 11(2). 387–92. 23 indexed citations

8.

Gu, Zhengming, D. Pim, Sylvie Labrecque, Lawrence Banks, & Greg Matlashewski. (1994). DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6.. PubMed. 9(2). 629–33. 38 indexed citations

9.

Moore, Kathryn J., Sylvie Labrecque, & Greg Matlashewski. (1993). Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction. The Journal of Immunology. 150(10). 4457–4465. 55 indexed citations

10.

Labrecque, Sylvie, et al.. (1993). Analysis of the anti-p53 antibody response in cancer patients.. PubMed. 53(15). 3468–71. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact